Medical Treatments: Cost Effectiveness
Commons · Question 77609 · Tabled 16 Sep 2025 · Department of Health and Social Care · Official record
Answered 27 Oct 2025
Question
Asked by Greg Smith
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the current NICE QALY threshold on (a) patient access to innovative medicines and (b) the UK’s competitiveness in attracting life sciences inv
Answer
Answered by Zubir Ahmed, 27 Oct 2025
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effectiv...